PI3K inhibition enhances the anti-tumor effect of eribulin in triple negative breast cancer. [electronic resource]

By: Contributor(s): Publication details: Oncotarget Jun 2019Description: 3667-3680 p. digitalISSN:
  • 1949-2553
 In: Oncotarget vol. 10
Tags from this library: No tags from this library for this title. Log in to add tags.
Star ratings
    Average rating: 0.0 (0 votes)
No physical items for this record

Publication Type: Journal Article

There are no comments on this title.

to post a comment.